Cordavis
biosimilar product market support
- B2B
About Cordavis
Collaboration with manufacturers to co-produce FDA-approved biosimilar products, ensuring affordability, quality, and patient ease of use.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11–50 employees
- Founded
- 2023
- Revenue
- $11.5M – $65.3MTamtam estimate
- Website
- cordavis.com
- linkedin.com/company/cordavis
Cordavis at a glance
Cordavis is a B2B company in the Pharmaceutical Manufacturing industry.
Cordavis was founded in 2023.
Cordavis has 11–50 employees.
Cordavis's revenue is $11.5M – $65.3M (Tamtam estimate).
Selling to companies like Cordavis?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies